Adrenocortical Carcinoma

Description

Adrenocortical carcinoma (ACC) is a cancer that arises from the adrenal cortex.

Clinical Features

Top most frequent phenotypes and symptoms related to Adrenocortical Carcinoma

  • Neoplasm
  • Muscle weakness
  • Pain
  • Hypertension
  • Abnormality of metabolism/homeostasis
  • Hyperhidrosis
  • Diabetes mellitus
  • Abdominal pain
  • Weight loss
  • Carcinoma

And another 23 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Based on the latest data available ADRENOCORTICAL CARCINOMA have a estimated incidence of 0.03 per 100k worldwide.
No data available about the known clinical features onset.

Researches and researchers

Doctors, researchs, and experts related to Adrenocortical Carcinoma extracted from public data.

Adrenocortical Carcinoma Experts map



Current Researchs and researchers

  • TORONTO — Dr David D MALKIN

    Investigator of research project

    • Institution/s:
      — Hospital for Sick Children, Research Institute
    • Research area/topic::

      Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers


  • WÜRZBURG — Pr Martin FASSNACHT

    Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Manager of registry - Manager of biobank/collection - Coordinator of research network

    • Institution/s:
      — Zentrum Innere Medizin (ZIM)
      — Universitätsklinikum Würzburg
    • Research area/topic::

      Mechanism of action of mitotane (o,p'-DDD) in adrenocortical carcinoma


  • ZÜRICH — Pr Felix BEUSCHLEIN

    Coordinator of expert centre - Clinical expert - Investigator of research project - Coordinator of research network

    • Institution/s:
      — UniversitätsSpital Zürich
    • Research area/topic::

      ENS@T-CANCER: European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults -terminated-


Adrenocortical Carcinoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
TP53 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
100 %
TP53 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
100 %
TP53 Sequence Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
100 %
TP53 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
100 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 %

You can get up to 416 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PARIETAL FORAMINA 2; PFM2 SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE MYHRE SYNDROME; MYHRS PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8 MACHADO-JOSEPH DISEASE; MJD MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54